| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,875 | 30,184 | 28,048 | 25,960 | | Cost of Revenue | 18,576 | 19,993 | 18,683 | 16,998 | | | Gross Profit | 9,299 | 10,191 | 9,365 | 8,962 | | | Operating Expenses | | Research Development | 769 | 800 | 903 | 838 | | Selling General and Administrative | 5,803 | 5,752 | 5,587 | 6,459 | | Non Recurring |
-
|
-
|
-
| 11,212 | | Others | 1,807 | 1,785 | 1,834 | 2,099 | | | | Total Operating Expenses |
-
|
-
|
-
| 20,608 | | | | Operating Income or Loss | 920 | 1,854 | 1,041 | (11,646) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 202 | 131 | 107 | 201 | | Earnings Before Interest And Taxes | 1,122 | 1,985 | 1,148 | (11,445) | | Interest Expense | 192 | 191 | 224 | 297 | | Income Before Tax | 930 | 1,794 | 924 | (11,742) | | Income Tax Expense | 52 | 340 | 88 | 296 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 878 | 1,454 | 836 | (12,038) | | | Non-recurring Events | | Discontinued Operations |
-
| (2) | (16) | 2,115 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 878 | 1,452 | 820 | (9,923) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $878 | $1,452 | $820 | ($9,923) |
|
0.51% Nasdaq 
Income Statement
